SCHEMBL18459253

SCHEMBL18459253

Cc1ccc([C@H]2C[C@H]2N)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 15/20 0.60
MAOB P27338 11/20 0.60
KCNH2 Q12809 3/20 0.60
RCOR1 Q9UKL0 3/20 0.60
KDM1B Q8NB78 2/20 0.60
MAOA P21397 8/20 0.59
CYP2C19 P33261 4/20 0.58
CYP2B6 P20813 3/20 0.58
CYP1A2 P05177 2/20 0.58
CYP2D6 P10635 2/20 0.58
CYP2C9 P11712 2/20 0.58
LMNA P02545 2/20 0.58
TAAR1 Q96RJ0 2/20 0.58
CYP3A4 P08684 1/20 0.58
HTR1A P08908 1/20 0.58
ADRA2A P08913 1/20 0.58
CYP2A6 P11509 1/20 0.58
SLC6A2 P23975 1/20 0.58
HTR2C P28335 1/20 0.58
ADRA1A P35348 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2755973 1.00 KDM1A (0.60) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL5729180 1.00 KDM1A (0.60) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL15235891 1.00 KDM1A (0.60) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL5729182 1.00 KDM1A (0.60) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL7093867 1.00 KDM1A (0.60) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL1290596 0.88 KDM1A (0.50) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL1290594 0.88 KDM1A (0.50) KDM1AMAOBKCNH2RCOR1KDM1B
SCHEMBL10224943 0.88 KDM1A (0.50) KDM1AMAOBKCNH2RCOR1KDM1B
Hydrochloric Acid SCHEMBL1290576 0.86 KDM1A (0.50) KDM1AMAOBKCNH2RCOR1KDM1B
Hydrochloric Acid SCHEMBL1290578 0.86 KDM1A (0.50) KDM1AMAOBKCNH2RCOR1KDM1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170029366-A1 INHIBITORS OF HISTONE LYSINE SPECIFIC DEMETHYLASE (LSD1) AND HISTONE DEACETYLASES (HDACS) THE JOHNS HOPKINS UNIVERSITY (US) 2017-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170029366-A1 INHIBITORS OF HISTONE LYSINE SPECIFIC DEMETHYLASE (LSD1) AND HISTONE DEACETYLASES (HDACS) KDM1B, KDM2A, EHMT2 KDM1A 4/4885MAOB 66/4885KCNH2 2056/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.